Skip to content

Kia Nikoomanesh

NPI 1902260375ActiveIndividual· Internal Medicine, Pulmonary Disease· Burbank, CA

Internal Medicine, Pulmonary Disease in Burbank, California, licensed in CA, with an NPI issued in April 2016. Part D covered 242 prescriptions written in 2024, 52% of them generic. Glaxosmithkline, LLC. was the largest of 16 companies reporting payments in 2025, $694.46 in all, mostly food and beverage.

Overview

NPI1902260375
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedApr 11, 2016
Last updated in NPPESMay 24, 2023
Certified by providerMay 24, 2023

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Internal Medicine (CA)

Part D prescriptions in 2024

Prescriptions (claims)242 · 325 30-day fills
Patients59
Total drug cost$71,370
Generic share52% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$694.46 · 28 payments from 16 companies
  • 2024$3,088 · 44 payments from 14 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$615.47 · 27 payments
  • Education$78.99 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Pulmonary Disease providers in Burbank

All Internal Medicine, Pulmonary Disease providers in California →